MINERALOCORTICOID ANTAGONIST INHIBITS STRESS-INDUCED BLOOD-PRESSURE RESPONSE AFTER REPEATED DAILY WARMING

被引:25
|
作者
VANDENBERG, DTWM
DEJONG, W
DEKLOET, ER
机构
[1] LEIDEN UNIV, LEIDEN AMSTERDAM CTR DRUG RES, DIV MED PHARMACOL, SYLVIUS LABS, 2300 RA LEIDEN, NETHERLANDS
[2] UNIV STRASBOURG 1, FAC MED, INST PHARMACOL, F-67000 STRASBOURG, FRANCE
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 1994年 / 267卷 / 06期
关键词
RAT; BRAIN; MINERALOCORTICOID RECEPTORS; CARDIOVASCULAR REGULATION; ADRENALS; HYPERTENSION; CORTICOSTERONE; ALDOSTERONE; ADRENOCORTICOTROPIC HORMONE;
D O I
10.1152/ajpendo.1994.267.6.E921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report here that with a direct method for measurement of cardiovascular parameters in conscious rats, intracerebroventricular administration of the mineralocorticoid receptor (MR) antagonist RU-28318 (100 ng) reduces the blood pressure, heart rate, and the corticosterone response to a brief restraint stress, provided the rats were previously subjected to a daily 30-min exposure to 32 degrees C for 2 wk. The daily exposure to warming and restraint stress are applied identically to the training procedure required for indirect blood pressure measurement using the tail-cuff method. The basal arterial pressure is not affected by the MR antagonist. The effect of the MR antagonist on the stress-induced presser response develops with a delay of several hours in the normotensive rats. The corticosterone response to daily warming and stress is also attenuated by the intracerebroventricular infusion of MR antagonist but with shorter onset and shorter duration. The findings suggest that conditioning to daily warming and stress imposes mineralocorticoid dependency of the presser response, which involves MR functioning in brain.
引用
收藏
页码:E921 / E926
页数:6
相关论文
共 40 条
  • [1] CENTRAL EFFECTS OF MINERALOCORTICOID ANTAGONIST RU-28318 ON BLOOD-PRESSURE OF DOCA-SALT HYPERTENSIVE RATS
    VANDENBERG, DTWM
    DEKLOET, ER
    DEJONG, W
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1994, 267 (06): : E927 - E933
  • [2] Stress-induced enhancement of response inhibition depends on mineralocorticoid receptor activation
    Schwabe, Lars
    Hoeffken, Oliver
    Tegenthoff, Martin
    Wolf, Oliver T.
    PSYCHONEUROENDOCRINOLOGY, 2013, 38 (10) : 2319 - 2326
  • [3] BLOOD-PRESSURE RESPONSE TO MENTAL STRESS
    FALKNER, B
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (11) : S621 - S623
  • [4] STRESS-INDUCED CHANGES IN BLOOD-PRESSURE AND LEFT-VENTRICULAR FUNCTION IN MILD HYPERTENSION
    LINDVALL, K
    KAHAN, T
    DEFAIRE, U
    OSTERGREN, J
    HJEMDAHL, P
    CLINICAL CARDIOLOGY, 1991, 14 (02) : 125 - 132
  • [5] ANALYSIS OF THE DAILY VARIATION IN BLOOD-PRESSURE AND PHARMACOKINETICS AFTER SINGLE OR REPEATED ADMINISTRATION OF CLENTIAZEM TO PATIENTS WITH ESSENTIAL-HYPERTENSION
    SUZUKI, S
    MORI, M
    KUSANO, S
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-1 (04): : 533 - 539
  • [6] ELEVATION OF BLOOD-PRESSURE AND HEMOCONCENTRATION INDUCED BY MENTAL STRESS
    FUJII, J
    IMATAKA, K
    HOMEOSTASIS IN HEALTH AND DISEASE, 1993, 34 (5-6): : 280 - 288
  • [7] Perfectionism Affects Blood Pressure in Response to Repeated Exposure to Stress
    Albert, Phebe
    Rice, Kenneth G.
    Caffee, Lauren
    STRESS AND HEALTH, 2016, 32 (02) : 157 - 166
  • [8] Ivabradine reduces baseline and stress-induced increase of heart rate and blood pressure and modulates neuroendocrine stress response in rats depending on stressor intensity
    Ondicova, Katarina
    Hegedusova, Noemi
    Tibensky, Miroslav
    Mravec, Boris
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2019, 38 (02) : 165 - 173
  • [9] Effects of rilmenidine on stress-induced peak blood pressure and renal function
    Fauvel, JP
    Najem, R
    Ryon, B
    Ducher, M
    Laville, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 34 (01) : 41 - 45
  • [10] EFFECTS OF LISINOPRIL ON STRESS-INDUCED PEAK BLOOD-PRESSURE AND SODIUM-EXCRETION - A DOUBLE-BLIND CONTROLLED-STUDY
    FAUVEL, JP
    LAVILLE, M
    BERNARD, N
    HADJAISSA, A
    DAOUD, S
    THIBOUT, E
    POZET, N
    ZECH, P
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) : 227 - 231